CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Ciclesonide nasal spray

Last Updated: May 7, 2008
Result type: Reports
Project Number: SR0137-000
Product Line: Reimbursement Review

Generic Name: Ciclesonide nasal spray

Brand Name: Omnaris

Manufacturer: Nycomed Canada Inc.

Therapeutic Area: Allergic Rhinitis (seasonal and perennial)

Indications: Allergic Rhinitis (seasonal and perennial)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: November 12, 2008

Recommendation Type: Do not list